Healthcare and Life Science
Closed Loop Medicine appoints Paul Johnson as Non-Executive Director
Appointment of digital healthcare leader to Board to support the Company as it enters next phase of commercial development Co-founder and former CEO of Lemonaid Health, a leading innovator in telemedicine and prescription drug delivery, acquired by 23andMe in 2021 London, UK, 22 M...
The science sector could be missing out on unlocking Neurodiverse potential by not knowing about this UK Government scheme
Companies in the science sector in the Cambridge area could be missing out on unlocking latent strengths of neurodiverse employees because they either don't know about or avoid using the UK Government's Access To Work Scheme. ...
UK proteostasis community comes together for a successful inaugural event
The UK’s proteostasis community came together for the first event of the UK Proteostasis Network at the Institute. ...
PhoreMost introduces GlueSEEKER platform for discovery of molecular glue degraders
New drug discovery platform integrates computational approaches with molecular biology for development of novel degrader therapeutics Cambridge, UK, 21 May 2024: PhoreMost Ltd., a leading UK biopharmaceutical company unlocking the next generation of drug targets, announces the introdu...
Deloitte Cambridge opens new business lounge
The Life Sciences Catalyst Business Lounge, designed to be a regional hotspot for start-ups and world-leading businesses in the life sciences sector, has been opened by Deloitte Cambridge. ...
Assessment of the impact of earlier access to disease-modifying treatments with more convenient administration frequency in reducing the socioeconomic burden for multiple sclerosis patients in Europe
The socioeconomic impact of Multiple Sclerosis (MS) extends to various areas of a patient’s life including personal wellbeing and mental health, family life and planning, employment and the lives of caregivers, which is associated with a significant economic and societal burden. Advance...
AT278 ultra-concentrated ultra-rapid acting insulin demonstrates superiority in Phase I Clinical Trial in overweight and obese people with type 2 diabetes
AT278 demonstrates significantly accelerated PK/PD profile compared to NovoRapid® and Humulin® R U-500 in people with Type 2 Diabetes and high BMI ...
ERS Genomics and IRBM sign CRISPR/Cas9 license agreement
License agreement provides IRBM access to CRISPR gene editing technology to be applied across its drug discovery services offering ...
How Meaningful Work Drives Employee Motivation
For many people, the pursuit of purpose and meaning has become a driving force behind employee motivation and engagement. Beyond traditional metrics like salary and benefits, employees are increasingly seeking opportunities to engage in work that aligns with their values and contributes...
New TV series sees surgeon carry out complex facial surgery after e-scooter incident
A leading Addenbrooke’s surgeon performed a complex operation following an e-scooter incident, in a powerful new TV series on treatments to the face, neck and head. ...